Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Well it seems Laurie is going to ignore my question
THIS REVISES AN EARLIER POST FOR WHICH I HAVE REQUESTED DELETION.

I distill your latest epistle down to "PDS got about a million so the whole contract was worth about $5 million based on the "20%" comment".

I'm not saying I agree with you, I'm taking a hypothetical position that you are correct.

So why didn't PDS get $4M as would have been the case, roughly, before TPL played the numbers game with the % split? Where was PTSC's fiduciary responsibility while this was all happening?

Are you also implying that TPL got 15% off the top from PDS, leaving about $850K to split and thus only about $425K to PTSC?
Share
New Message
Please login to post a reply